Corporate Banner
Satellite Banner
Technology Networks Header
Monday, November 24, 2014
Technology Networks
Register | Sign in
Home Page>News

  News Archive

Genticel Completes Procervix Phase II Study Enrollment Ahead of Schedule
Saturday, November 15, 2014
A total of 239 subjects infected with HPV 16 and/or 18 enrolled at 39 clinical centers throughout Europe for RHEIA-VAC study of ProCervix.

Almac Announces Launch of CLIA Validated Next Generation Sequencing Assay
Thursday, November 13, 2014
P53 considered important biomarker for cancer drug discovery.

Advent International Sign Agreement with Avista Capital Partners
Thursday, November 13, 2014
Agreement to acquire Kremers Urban Pharmaceuticals from UCB.

ICON Selected by the FDA to Develop New PRO Measure for HABP Trials
Thursday, November 13, 2014
New PRO measure being developed in conjunction with the FNIH Biomarkers Consortium.

Charles River and CHDI Foundation Extend Huntington’s Disease Collaboration
Thursday, November 13, 2014
CHDI extends its ongoing collaboration for an additional five years through to 2019.

West Receives 510(k) Clearance for NovaGuard™ SA Safety System
Thursday, November 13, 2014
Staked-needle prefillable syringe safety system helps reduce risk of needlestick injury to healthcare workers and patients.

GE Healthcare and Takeda Join Forces
Thursday, November 13, 2014
This alliance is key to enabling the early development of therapeutic drugs through the use of a minimally invasive diagnostic technology.

PAREXEL Expands Clinical Trial Supply and Logistics Services
Thursday, November 13, 2014
Facility in Berlin-Schönefeld, Germany delivers end-to-end supply chain management and distribution services.

Cirrus Pharmaceuticals to Invest in cGMP Manufacturing Suite in US
Thursday, November 13, 2014
Company will be able to extend its offerings in the US from contract development to manufacturing.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 3269
SELECTBIO Market Reports
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to